Eone Diagnomics Genome Center Co.Ltd. (KOSDAQ:A245620) agreed to acquire remaining 51.07% stake in EDGC Healthcare Co., Ltd for approximately KRW 140 billion on May 25, 2020. As part of the acquisition, Eone Diagnomics Genome Center Co.Ltd. will acquire 3.2 million shares of EDGC Healthcare Co., Ltd at merger ratio of 1:3.18936. As of December 31, 2019, EDGC Healthcare has a total assets of KRW 41.6 billion, total capitaliq of KRW 13.3 billion and net income of KRW 2.7 billion. Post the acquisition, EDGC Healthcare Co., Ltd. will be merged into Eone Diagnomics Genome Center Co.Ltd. and dissolved. The transaction is expected to complete on August 6, 2020. As of July 3, 2020, the transaction has been approved by the Board of Directors and shareholders of Eone Diagnomics Genome Center.